The Native Antigen Company, a suppier of infectious disease antigens and antibodies, has signed a pre-let for a 49,000 sq ft purpose-built R&D and manufacturing facility at the Oxford Technology Park.
Native Antigen Signs Pre-Let for 50,000 Sq Ft R&D facility at Oxford Technology Park
Two-Storey Building Will Be Ready by Summer 2021
By Sharon Smyth
CoStar News
November 3, 2020 | 9:27 AM
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In